Page 5 - Swedish (OMX) Pharmaceuticals & Biotech Stocks - Top Gainers Today

UPDATED May 17, 2024

Explore the Swedish (OMX) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.

124 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

CSMED

CS Medica
kr.6.01-7.8%-36.2%kr.47.4mn/aPS69.4xn/an/a

GABA

Gabather
kr1.82-11.9%-57.8%kr34.3mn/aPB70.5xn/an/a

ODI

ODI Pharma
kr7.20-4.6%50.6%kr109.6mn/aPS133.9xn/an/a

ABLI

Abliva
kr0.20-2.1%-5.8%kr246.5mn/aPS1799.3xE-23.4%n/a

ENZY

Enzymatica
kr3.17-0.9%-2.5%kr549.6mkr4.44PS11.6xE76.2%n/a

SPRINT

Sprint Bioscience
kr1.24-6.5%72.2%kr86.6mkr2.90PE9.9xS31.4%n/a

ACE

Ascelia Pharma
kr9.28-2.3%-40.1%kr313.3mkr16.75PB5xE-43.0%n/a

CURAS

Curasight
kr.9.30-4.7%-49.9%kr.185.0mkr.29.00PB5.9xn/an/a

XBRANE

Xbrane Biopharma
kr0.20-2.9%-99.8%kr309.0mn/aPS1.3xE93.7%n/a

CANTA

Cantargia
kr3.60-1.5%-25.6%kr661.3mkr12.67PB3.9xE60.1%n/a

IVACC

Intervacc
kr4.35-3.1%-20.5%kr329.5mkr8.00PS36.9xE34.6%n/a

EEVIA

Eevia Health Oyj
kr0.73-55.9%-67.6%kr26.0mn/aPB0.5xn/an/a

GUARD

Guard Therapeutics International
kr36.80-4.2%479.5%kr370.3mkr65.00PB7xE-6.3%n/a

ATORX

Alligator Bioscience
kr0.89-2.6%76.7%kr673.9mkr1.90PS12xE48.1%n/a

ONCO

Oncopeptides
kr2.78-4.0%-66.4%kr609.8mkr6.40PS17.3xE32.2%n/a

BIOT

Biotage
kr179.10-0.2%22.7%kr14.3bkr186.67PE60.7xE19.9%0.9%

BICO

BICO Group
kr43.88-1.0%-24.6%kr3.1bkr132.50PS1.3xE161.9%n/a

PROB

Probi
kr205.00-1.4%9.0%kr2.3bn/aPS3.8xE71.1%0.6%

DVYSR

Devyser Diagnostics
kr99.80-2.6%23.5%kr1.6bkr126.15PS9xE99.0%n/a

GENO

Genovis AB (publ.)
kr33.80-2.0%-40.7%kr2.2bkr51.50PE72.1xE13.6%n/a

VICO

Vicore Pharma Holding
kr19.70-2.5%-19.9%kr2.2bkr61.50PS21.1xE10.4%n/a

SECARE

Swedencare
kr55.05-0.7%35.8%kr8.7bkr67.00PE122.2xE50.2%0.4%

MOB

Moberg Pharma
kr24.70-9.5%10.8%kr690.6mkr24.50PS842.3xE65.5%n/a

HNSA

Hansa Biopharma
kr36.50-3.0%-29.5%kr2.3bkr105.00PS13.9xE27.3%n/a
Page 5 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.